Search Results - "Gessoni, F."

Lack of rivaroxaban influence on a prothrombinase‐based assay for the detection of activated C protein resistance: an Italian ex vivo and in vitro study in normal subjects and factor V Leiden carriers by Gessoni, G., Valverde, S., Valle, L., Gessoni, F., Caruso, P., Valle, R.

“…Summary Introduction Activated protein C resistance (APCr) leads to hypercoagulability and is due, often but not exclusively, to Factor V Leiden (FVL). The aim…”
Get full text

PO-1117 HER2 expression correlated with intracranial control and prognosis of breast cancer brain metastases by Caroli, A., Revelant, A., Bertini, F., Gessoni, F., Vinante, L.

Get full text

PO-1500 Stereotactic Body Radiation Therapy for oligorecurrent thymoma: a monocentric experience by Sepulcri, M., Paronetto, C., Santoro, V., Gorza, A., Gessoni, F., Scaggion, A., Fusella, M., Muraro, M.

Get full text

Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study by Gessoni, F., Matrone, F., Pirrone, G., Polesel, J., Vinante, L., Caroli, A., Donofrio, A.A.M., Bertini, F., Fanetti, G., Navarria, F., Malfatti, G., Barresi, L., Drigo, A., Mascarin, M., Revelant, A.

“…Limited second-line therapeutic options are available in Malignant Pleural Mesothelioma (MPM). In this patients Stereotactic Ablative Body Radiotherapy (SABR)…”
Get full text

PO-1608 Synergistic effect of stereotactic radiotherapy and immunotherapy: an italian multicentric study by Gorza, A., Fanetti, G., Baggio, V., Turturici, I., Servodio, O., Revelant, A., Gessoni, F., Minissale, A.F.S., Matrone, F., Bertini, F., Donofrio, A., Moro, M., Chiovati, P., Ferrarese, F., Mascarin, M.

Get full text